Novartis drug Gilenya® shows long-term efficacy and safety according to new data from extension of phase III head-to-head study Novartis, 11 Jun 2012 Accessed on 12 Jun 2012 from http://www.novartis.com/newsroom/media-releases/en/2012/1618585.shtml. CommentRecommendBookmarkWatch